March is National Colorectal Cancer Awareness Month

March is Colorectal Cancer Awareness Month. This month, Charleston Oncology recognizes the importance of spreading awareness surrounding the disease.

Colorectal cancer is the third most common cancer diagnosed in men and women in the United States. The lifetime risk of developing colorectal cancer is around 1 in 23 for men and 1 in 26 for women; however, this number can differ depending on an individual’s risk factors.

Provider Gene B. Saylors, MD, encourages those 45 years of age and those with a family history of colorectal cancer to complete screenings routinely. “It’s a highly curable illness if caught early, and we can save lives by pursuing active screening,” according to Saylors.

For more information or to schedule an appointment or call one of our locations to schedule an evaluation.

Send UsA Message

    Melanoma Prevention and Awareness

    Melanoma Prevention and Awareness

    May is Skin Cancer Awareness Month. Melanoma is a type of skin cancer that develops when melanocytes (the cells that give the skin its tan or brown color) start to grow out of control. Watch the video to learn more about melanoma from Charleston Oncology’s Dr. Charles S. Holladay.

    read more
    Staying Aware for Breast Cancer Awareness Month

    Staying Aware for Breast Cancer Awareness Month

    Staying Aware for Breast Cancer Awareness monthCharleston Oncology is proud to sponsor Staying Aware for Breast Cancer Awareness month in conjunction with WCIV News Channel 4. We continue to partner with our community to ensure that every woman has the best chance of...

    read more
    Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World

    Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World

    Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”

    read more
    Call Now Button